International Clinical Trial: Evaluation of the safety of the intravenously (IV) administered psychedelic, psilocin in healthy adults.

Geneva, May 20 -- International Clinical Trials Registry received information related to the study (ACTRN12625000403437) titled 'Evaluation of the safety of the intravenously (IV) administered psychedelic, psilocin in healthy adults.' on May 5.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Non-randomised trial Masking: Open (masking not used) Assignment: Single group Type of endpoint: Safety

Primary Sponsor: Tryptamine Theraputics

Condition: Binge Eating Disorder Binge Eating Disorder Mental Health - Eating disorders

Intervention: INTERVENTIONAL: This is a phase 1 open label uncontrolled trial of TRP-8803 (Psilocin Besylate) administered intravenously in conjunction with psychedelic-assisted psychotherapy...